You are currently viewing New Study Links Ozempic to Severe Gastrointestinal Problems

New Study Links Ozempic to Severe Gastrointestinal Problems

Recent research has highlighted a potential downside to popular weight loss medications, including Ozempic and other related drugs like Wegovy, Rybelsus, and Saxenda. These drugs, known as agonists of GLP-1, have been linked to serious digestive issues. According to a study from the University of British Columbia (UBC), these medications may increase the risk of severe gastrointestinal problems such as stomach paralysis, pancreatitis, and bowel obstruction.

This is particularly noteworthy as it’s the first large-scale study to investigate adverse gastrointestinal events in non-diabetic people using these drugs solely for weight loss. The findings, published in the JAMA (Journal of the American Medical Association), raise important questions about the safety of these widely used weight loss aids. As these drugs continue to gain popularity, understanding their potential risks is crucial for ensuring safe and effective use. Further in this blog, we’ll discuss the growing concern of gastrointestinal conditions highlighted in this new study, along with other related side effects. We will also explore the global impact of these side effects and whether it is possible to take Ozempic without experiencing them.

Gastrointestinal Conditions: A Growing Concern

GLP-1 agonists, initially developed for Type 2 diabetes management, have surged in popularity as a weight-loss aid, with around 40 million prescriptions in the USA. in 2022, according to the data published in Jama. Despite their benefits, these drugs can have severe but rare possible side effects, especially concerning the gastrointestinal system. Patients considering these medications for weight loss should weigh the risks, which may vary based on their health goals, whether for diabetes, obesity, or general weight loss. Healthy people might be more cautious about accepting these potential risks.

The Study Findings

It was only in 2021 that some versions of these medicines were approved for treating obesity. However, the clinical trials that looked at how well these medications work for weight loss weren’t set up to catch rare gastrointestinal problems. This is because the trials had a small number of people in them and didn’t follow up with them for a long time.

There have been anecdotal reports of some patients experiencing nausea and vomiting, potentially due to a condition called gastroparesis, after using weight-loss drugs. But, there hasn’t been solid evidence from extensive studies to support this. To address this lack of information, researchers from the UBC reviewed health insurance records for about 16 million patients in the USA. They focused on those who were prescribed semaglutide or liraglutide, two common weight-loss medications (both are GLP-1 agonists), from 2006 to 2020. They specifically looked at patients with a recent history of obesity and excluded patients with diabetes or those who were prescribed other diabetes medications. 

How High Are These Risks of Side Effects?

The researchers examined patient records to determine how many individuals developed one of four specific gastrointestinal issues. They then compared this incidence rate with patients who were taking a different weight-loss medication, bupropion-naltrexone. The findings showed that compared to those on bupropion-naltrexone, patients using GLP-1 agonists were linked with a: 

  • 9.09 times higher chance of getting pancreatitis (a condition that occurs when your pancreas gets inflamed). This can cause severe stomach pain and sometimes needs hospitalization and surgery.
  • 4.22 times higher chance of having a bowel obstruction, which stops food from moving through the intestines (including both small or large intestines). This can lead to bloating, cramping, and feeling sick. Surgery might be needed in serious cases.
  • 3.67 times higher chance of getting gastroparesis or stomach paralysis. This slowing down movement of food from the stomach to the intestine (small) can cause vomiting, nausea, and stomach pain.

The Global Impact of These Side Effects

The widespread use of these medications has a significant global impact. Even a small risk of 1% can affect a large number of people due to the increased use of these drugs. Between 2020 and 2022, prescriptions for these drugs rose by 300%, partly because they were used for weight loss, not just their original purpose. This means that potentially hundreds of thousands of people around the world could experience serious digestive issues as a side effect.

The study also noted a higher occurrence of biliary disease, which affects the gallbladder, but this difference wasn’t considered significant statistically. Despite these side effects being rare, with millions of people worldwide using these drugs, it could still result in a large number of individuals experiencing these conditions. The increasing accessibility of these drugs is problematic, especially since some people can easily order them online without fully understanding the potential risks. This situation challenges the principle of informed consent, where individuals should be fully aware of the risks and other important safety information before using any medication.

Can You Take Ozempic Without Experiencing Side Effects?

Taking Ozempic doesn’t necessarily mean you’ll experience side effects. In fact, the majority of people using Ozempic, over 80%, report mild or no side effects at all, according to NIH (National Institute of Health). It might seem like side effects are common because those who do experience them or fear them tend to share their experiences online. There’s no guarantee that you’ll encounter side effects, so it’s important not to assume the worst. It’s crucial to make informed choices when considering these medications, weighing the risks against the benefits. This is particularly important for those who are generally healthy and looking for weight loss solutions. In light of recent studies, regulatory bodies and pharmaceutical companies may need to consider updating their warning labels to include the risk of gastroparesis.

Both patients & healthcare providers need to understand the risks associated with using GLP-1 agonists for weight management or diabetes control. Being aware of these side effects is key to making well-informed choices about treatment. If patients notice any symptoms related to gastrointestinal issues, they should seek medical help immediately to prevent serious problems. Ongoing research is expected to lead to updates in warning labels by regulatory bodies and drug manufacturers, highlighting the risk of gastroparesis and other digestive issues. As always, consult your healthcare professional before beginning or discontinuing your medication and discuss any concerns you may have about the side effects of these popular weight loss medications.

Wrapping It Altogether

While the potential risks associated with medications like Ozempic are a concern, it’s important to view them in the context of the overall health picture. Obesity itself carries significant risks, including a higher chance of heart disease (such as strokes), diabetes (type 2), and cancer. For many people using Ozempic, the benefits of significant and lasting weight loss might outweigh the risks these medications pose.

Meanwhile, this study underscores the importance of a balanced approach when considering popular weight loss medications. Both patients and healthcare providers should carefully weigh the potential risks and benefits. Decisions about treatment should be based on a thorough understanding of the person’s medical history and the evidence available. 


[Note:Buy Ozempic online Canada at the lowest price possible and get it shipped to your doorsteps in the USA.]

Leave a Reply